Mon Dec 20, 2021 – 8:40 pm EST
NEW YORK (LifeSiteNews) — The top eight Pfizer and Moderna shareholders saw their combined wealth rise by $10 billion in a seven-day windfall after the Omicron variant was discovered, according to a report in the Daily Mail.
With the discovery of Omicron making headlines globally from November 24, the personal wealth of Moderna CEO Stephane Bancel rose by $824 million alone amid the company’s rapid share growth, with the pharma boss selling 10,000 shares of his own stock in that period for a cool $3.19 million.
Investment giant Vanguard Group Inc. saw the value of its shareholdings in Pfizer and Moderna increase by more than $2.7 billion after the Omicron news, with Blackrock Inc.’s shares rising by more than $2.4 billion and Baillie Gifford & Co’s Moderna stock valuation climbing by more than $1.5 billion.
State Street Corp.’s Pfizer shareholdings increased in value by more than $1 billion, and Capital World Investors’ shares rose by more than $900 million, followed closely by Bancel’s $824 million and Flagship Pioneering’s $652 million gain on Moderna stock.
Bancel’s share value reportedly rose by $1.7 billion at one point during the last week of November, but a lost legal dispute concerning company
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors